Skip to main content
    • Aa
    • Aa

Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache

  • J A de Ru (a1) and J Buwalda (a1)

To describe our results with botulinum toxin type A injection for headache in carefully selected patients, and to present the rationale behind this therapy.


Tertiary referral centre.

Patients and methods:

This article describes a case series of 10 consecutive patients with frontally localised headache, whose pain worsened when pressure was applied at the orbital rim near the supratrochlear nerve. The patients received a local anaesthetic nerve block with Xylocaine 2 per cent at this site. If this reduced the pain, they were then offered treatment with botulinum toxin.


Injection with 12.5 IU of botulinum toxin A into the corrugator supercilii muscle on both sides (a total of 25 IU).

Main outcome measure:

Pain severity scoring by the patients, ranging from zero (no pain) to 10 (severe pain) on a verbal scale.


Following injection, all patients had less pain for approximately two months. This treatment did not appear to have lasting side effects.


Xylocaine injection is a good predictor of the effectiveness of botulinum toxin injection into the corrugator muscle as treatment of frontally localised headache. We hypothesise that this pain is caused by entrapment of the supratrochlearis nerve in the corrugator muscle. Furthermore, we found botulinum toxin injection to be a safe and effective means of achieving pain relief in this patient group.

Corresponding author
Address for correspondence: Dr J A de Ru, ENT Surgeon, Department of Otolaryngology-Head Neck Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Fax: 0031 302541922 E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1 DW Dodick , A Mauskop , AH Elkind , R DeGryse , MF Brin , SD Silberstein . Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 2005;45:315–24

2 A Pakalnis , J Couch . Headache therapy with botulinum toxin: form over substance. Arch Neurol 2008;65:149–51

3 NT Mathew , BM Frishberg , M Gawel , R Dimitrova , J Gibson , C Turkel . Botulinum toxin type A (Botox) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005;45:293307

4 SD Silberstein , SR Stark , SM Lucas , SN Christie , RE DeGryse . Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005;80:1126–37

5 BS Schwartz , WF Stewart , D Simon , RB Lipton . Epidemiology of tension-type headache. JAMA 1998;279:381–3

6 M Padberg , SFTM De Bruijn , RJ De Haan , DLJ Tavy . Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia 2004;24:675–80

7 JD Rollnik , O Tanneberger , M Schubert , U Schneider , R Dengler . Treatment of tension-type headache with botulinum toxin type A: a double blind, placebo-controlled study. Headache 2000;40:300–5

10 N Barrientos , P Chana . Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study. J Headache Pain 2003;4:146–51

11 WJ Schulte-Mattler , P Krack . Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double blind, placebo-controlled multicenter study. Pain 2004;109:110–4

12 EJ Eross , JP Gladstone , S Lewis , R Rogers , DW Dodick . Duration of migraine is a predictor for response to botulinum toxin type A. Headache 2005;45:308–14

13 A Ashkenazi , SD Silberstein . Botulinum toxin and other new approaches to migraine therapy. Ann Rev Med 2004;55:505–8

14 A Ashkenazi , S Silberstein . Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol 2008;65:146–9

15 ES Roach . Questioning botulinum toxin for headache: reality or illusion. Arch Neurol 2008;65:151–2

16 F Dirnberger , K Becker . Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg 2004;114:652–7

17 WH Bearden , RL Anderson . Corrugator superciliaris muscle excision for tension and migraine headaches. Ophthal Plast Reconstr Surg 2005;21:418–22

19 B Guyuron , A Varghai , BJ Michelow , T Thomas , J Davis . Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg 2000;106:429–34

21 TJ Schwedt , JG Hentz , DW Dodick . Factors associated with the prophylactic effect of placebo injections in subjects enrolled in a study of botulinum for migraine. Cephalalgia 2007;27:528–34

23 WJ Schmitt , E Slowey , N Fravi , S Weber , J-M Burgunder . Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001;41:658–64

25 JA Smuts , D Schultz , A Barnard . Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study. Headache 2004;44:801–5

26 S Mosser , B Guyuron , J Janis , R Rohrich . The anatomy of the greater occipital nerve: implications for the etiology of migraine headaches. Plast Reconstr Surg 2004;113:693–7

27 C Fernández de las Peñas , ML Cuadrado , L Arendt Nielsen , DG Simons , JA Pareja . Myofascial trigger points and sensitization: an updated pain model for tension-type headache. Cephalalgia 2007;27:383–93

29 JM McPartland , DG Simons . Myofascial trigger points: translating molecular theory into manual therapy. J Man Manipul Therapy 2006;14:232–9

30 K-Y Ho , K-H Tan . Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review. Eur J Pain 2007;11:519–27

31 T Muehlberger , P Fisher , M Lehnhardt . The anatomy of the surgical treatment of migraine [in German]. Zentralbl Chir 2005;130:288–92

32 JJ Dutton , AM Fowler . Botulinum toxin in ophthalmology. Surv Ophthalmol 2007;52:1331

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 1
Total number of PDF views: 11 *
Loading metrics...

Abstract views

Total abstract views: 88 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 26th June 2017. This data will be updated every 24 hours.